A randomized clinical trial comparing the effectiveness and tolerability of artemisinine-naphthoquine (Arco®) and artemether-lumefantrine (Coartem®) in the treatment of uncomplicated malaria in Benin;Essai clinique randomisé comparant l'efficacité et la tolerance de la combinaison artémisinine-naphthoquine (Arco®) et artéméther-luméfantrine (Coartem®) dans le traitement du paludisme simple au Bénin

Bulletin de la Societe de Pathologie Exotique

Volumn 105, Issue 3, 2012, Pages 208-214

  Kinde Gazard, D ^a   Ogouyemi Hounto A ^a   Capo Chichi, L ^a   Gbaguidi, J ^a   Massougbodji, A ^a  

^a NONE

Author keywords

Artemether lumefantrine; Artemisinin naphthoquine; Benin; Efficacy; Hospital; Malaria; Subsaharan Africa; Tolerability; Zinvie

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ARTEMISININ NAPHTHOQUINE COMBINATION; ARTEMISININ-NAPHTHOQUINE COMBINATION; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE; NAPHTHOQUINONE;

ADOLESCENT; ARTICLE; BENIN; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; HUMAN; INFANT; MALARIA; MALE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ADOLESCENT; ANTIMALARIALS; ARTEMISININS; BENIN; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; INFANT; MALARIA; MALE; NAPHTHOQUINONES; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84865195072     PISSN: 00379085     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13149-012-0211-7     Document Type: Article

References (22)

1. Achan J, Tibenderana JK, Kyabayinze D, et al (2009) Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. BMJ 339:b2763
2. Assefa A, Kassa M, Tadese G, et al (2010) Therapeutic efficacy of artemether/lumefantrine (Coartem®) against Plasmodium falciparum in Kersa, South West Ethiopia. Parasit Vectors 3(1):1
3. Aubouy A, Fievet N, Bertin G, et al (2007) Dramatically decreased therapeutic efficacy of chloroquine and sulfadoxine-pyrimethamine, but not mefloquine, in southern Benin. Trop Med Int Health 12(7):886-94 (Pubitemid 46998287)
4. Falade C, Makanga M, Premji Z, et al (2005) Efficacy and safety of artemether-lumefantrine (Coartem®) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 99(6):459-67 (Pubitemid 40521344)
5. Faye B, Ndiaye JL, Tine R, et al (2010) A randomized trial of artesunate mefloquine versus artemether lumefantrine for the treatment of uncomplicated Plasmodium falciparum Malaria in Senegalese Children. Am J Trop Med Hyg 82(1):140-4
6. Hombhanje FW, Linge D, Saweri A, et al (2009) Artemisinin- naphthoquine combination (Arco®) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy. Malar J 8:196
7. Hombhanje FW, Qingyun H (2010) Artemisinin-naphthoquine combination (Arco®): an overview of the progress. Pharmaceuticals 3:3581-93
8. Hutagalung R, Paiphun L, Ashley EA, et al (2005) A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand. Malar J 4:46
9. Imbert P, Gendrel D (2002) Traitement du paludisme chez l'enfant. Med Trop 62(6):657-64
10. Institut Pasteur de Côte d'Ivoire. Observatoire de la résistance aux antipaludiques
11. Kamya MR, Yeka A, Bukirwa H, et al (2007) Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. PLoS Clin Trials 2(5):20
12. Kassa M, Mariam AH, Sileshi M, et al (2009) High efficacy of artemether-lumefantrine three years after use as first line drug for the treatment of uncomplicated falciparum malaria in Wondo Genet, South-central Ethiopia. 5th MIM Pan-African Malaria Conference [www.mimalaria.org/eng/docs/ pdfs/events/Book-of-Abstracts.pdf
13. Kateera F, Dorsey G, Achan J, et al (2009) Efficacy, safety and tolerability of amodiaquine-artesunate versus artemether-lumefantrine for the treatment of uncomplicated malaria in HIVinfected children in Kampala, Uganda. 5th MIM Pan-African Malaria Conference [www.mimalaria.org/eng/docs/pdfs/events/ Book-of-Abstracts.pdf]
14. Kunming Pharmaceutical Corp (2009). Monograph of Arco® tablets (Artemisinin-naphthoquine phosphate), first edition, March 66 p
15. Maiteki-Sebuguzi C, Jagannathan P, Yau VM, et al (2009) Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. 5th MIM Pan- African Malaria Conference [www.mimalaria.org/eng/docs/pdfs/events/Book-of-Abstracts.pdf]
16. Mworozi AE, Rujumba J, Kiguba R, et al (2009) A single blinded clinical trial comparing Arco® a new antimalarial drug and Coartem® in the treatment of uncomplicated malaria in adult patients in Uganda. 5th MIM Pan-African Malaria Conference [www.mimalaria.org/eng/docs/pdfs/events/Book-of- Abstracts.pdf]
17. Nigerian-German Chemicals PLC (2005) Arco® the new way to treat malaria. [www.ngcplc.com/arco/index.htm]
18. Organisation mondiale de la Santé (2001) Les combinaisons thérapeutiques antipaludiques. Rapport d'une consultation technique de l'OMS. WHO/CDS/RBM/2001.35
19. Organisation mondiale de la Santé (2004) Évaluation et surveillance de l'efficacité des antipaludiques dans le traitement du paludisme à Plasmodium falciparum non compliqué. OMS Genève, Document WHO/RBM/2003.50, 67 p
20. Toure OA, Penali LK, Yapi JD, et al (2009) A comparative, randomized clinical trial of artemisinin/naphtoquine twice daily one day versus artemether/lumefantrine six doses regimen in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire. Malar J 8:148
21. Tun T, Tint Hs, Lin K, et al (2009) Efficacy of oral single dose therapy with artemisinin-naphthoquine phosphate in uncomplicated falciparum malaria. Acta Trop 111(3):275-8 Epub
22. Wang JY, Cao WC, Shen CQ, et al (2004) Naphthoquine phosphate and its combinations with artémisinine. Acta Trop 89(3):375-81